Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise ...
RAPT is closing two Phase II trials for Rapt’s lead candidate, zelnecirnon, thre...
The positive Phase I/II data has supported a RMAT designation from the FDA and a...
The FDA has given an IND approval for WestGene’s mRNA therapeutic cancer vaccine...
Discover key insights into the selection of oral solid dosage manufacturing comp...
You hear a phone ring or a dog bark. Is it yours or someone else’s? You hear foo...
RICHLAND, Wash.—Nature is filled with extraordinarily precise molecular shapes t...
By Eddy Duryea ’13 Credit: Antoine Hart, University of Central Florida By Eddy D...
The global move toward more sustainable, green energy has increased power reserv...
Many artificial intelligence (AI) systems have already learned how to deceive hu...
New research from Memorial Sloan Kettering Cancer Center (MSK) measures unschedu...
Toronto – A new book by a business historian at the University of Toronto tells ...
The latest inaugural lecture at Aston University will look at the complex relati...
Credit: Gaëtan Jargot, PhD, Research Associate, Institut national de la recherch...
What do infants see? What do they look at? The answers to these questions are ...
With the emergence of internet services such as AI-generated content and virtual...